Creative Biolabs develops and commercializes a full range of integrated innovative services that are based on phage display technology. We have ...
Creative Biolabs can offer advanced protein engineering platform for your specific project, including high-scale expression, crystallization and characterization...
Creative Biolabs has established custom membrane protein and membrane protein antibody production platforms for antibody discovery...
Creative Biolabs provides a full range of services based on our matured hybridoma platform. Our featured services involve the custom monoclonal antibody production, from ...
Creative Biolabs together with partners has developed an unparalleled platform of yeast target-based assays for antibody drug discovery. The use of these assays in the early phase of the screening will greatly reduce the costs and will expedite the discovery of new regulators of specific therapeutic targets. The yeast target-based approach can be highly useful in the first-line screening of potential active compounds to be tested in more complex cell models.
The high degree of cellular processes conservation between the yeast Saccharomyces cerevisiae and higher eukaryotes has made this microorganism a valuable cell model to study the pathobiology of several human diseases. Moreover, the possibility of reproducing the function of disease-associated human proteins without orthologues in yeast has allowed an independent analysis of a wide range of human proteins (or simplified networks of human proteins) in a simpler eukaryotic environment. This humanized yeast model has emerged as a powerful tool in large-scale screenings directed to target human proteins.
Benefits of these assays over other existing technologies include:
a) The possibility to search against a specific molecular target, overcoming the limitation of the traditional drug discovery strategy that implicates the subsequent identification of the drug target, which is a costly and complex task;
b) With a simpler eukaryotic cellular environment, it eliminates the interference of other proteins with similar functions, endogenous regulators and redundant cellular processes;
c) Easier and lower-cost manipulation;
d) Easier and faster propagation in high-throughput screening automated systems;
e) The possibility for an immediate analysis of relevant drug properties, such as cellular permeability, instability and cytotoxicity.
We have specifically developed several yeast target-based assays direct to major therapeutic targets, particularly in cancer:
Select Product Citations
Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us